DOUGLAS DAVIS: Open Payments
NPI 1083669345 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 24 payments from 12 companies in 2025. Trend: 2023 $738 · 2024 $490 · 2025 $424
Food & beverage: $405Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $113 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novo Nordisk Inc | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Tonix Medicines, Inc. | 1 | $29 |
| Soleno Therapeutics, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: LEQVIO, AIRSUPRA, GVOKE HYPOPEN, Wegovy, NEXLETOL, TONMYA, VYKAT XR, SHINGRIX.
Industry payments across TN — which companies pay providers there.
